Drug profile · INN
maprotiline hydrochloride
MAPROTILINE HYDROCHLORIDE
maprotiline hydrochloride (MAPROTILINE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Beam Therapeutics. Route of administration: oral. Current US regulatory status: approved.
Drug details — maprotiline hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 10
- Programs
- 0
- Data quality
- 0.89
Quick answer
maprotiline hydrochloride (MAPROTILINE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Beam Therapeutics. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
-
US 12296053
Nanomaterials comprising triols
granted -
US 12268753
Nanomaterials comprising a biodegradable feature
granted -
US 12059477
Nanomaterials
granted -
US 12016908
Compositions and methods for treating hemoglobinopathies
granted -
US 11752202
Compositions and methods for treating hemoglobinopathies
granted -
US 11594345
Method for producing Ac-225 from Ra-226
granted -
US 11344609
Compositions and methods for treating hemoglobinopathies
granted -
US 11142760
Compositions and methods for treating hemoglobinopathies
granted -
US 10919019
Apparatus for the synthesis of radiopharmaceutical products
granted -
US 8287819
Device for synthesis of radiopharmaceutical products
granted
Frequently asked questions
What is maprotiline hydrochloride?
maprotiline hydrochloride (MAPROTILINE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Beam Therapeutics. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for maprotiline hydrochloride?
MAPROTILINE HYDROCHLORIDE is a marketed brand name for maprotiline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of maprotiline hydrochloride?
maprotiline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.